Research programme: vaccines - BioNet-Asia

Drug Profile

Research programme: vaccines - BioNet-Asia

Alternative Names: CRM197 conjugate vaccine - BioNet Asia; Human papilloma virus vaccine - BioNet Asia; Paediatric vaccine - BioNet Asia; Recombinant hepatitis B vaccione - BioNet Asia

Latest Information Update: 08 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator BioNet-Asia
  • Class Bacterial vaccines; Conjugate-vaccines; Vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Unspecified
  • Research Diphtheria; Hepatitis B; Human papillomavirus infections

Most Recent Events

  • 31 Aug 2016 Early research in Diphtheria (Prevention) in Thailand (Parenteral) (BioNet Asia pipeline, August 2016)
  • 31 Aug 2016 Early research in Hepatitis B (Prevention) in Thailand (Parenteral) (BioNet Asia pipeline, August 2016)
  • 31 Aug 2016 Early research in Human papillomavirus infections (Prevention) in Thailand (Parenteral) (BioNet Asia pipeline, August 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top